Vaxart Answers Additional Frequently Asked Questions from Retail Investors
Globenewswire· 2025-05-28 12:00
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" OR "Vaxart") today answers additional frequently asked stockholder questions it has received from retail investors in advance of the Company's Annual Meeting of Stockholders scheduled to take place on Monday, June 2, 2025. "We appreciate the continued interest from our passionate and loyal stock ...
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
Globenewswire· 2025-05-28 12:00
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that enrollment is complete in the sunRIZE study, a global, Phase 3 multicenter, double-blind, randomized, placebo-controlle ...
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
Globenewswire· 2025-05-28 12:00
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia's mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com. Forward Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 2 ...
Gentex Announces Second Quarter 2025 Cash Dividend
Globenewswire· 2025-05-28 12:00
Contact Information Gentex Investor Relations 616-931-3505 This press release was published by a CLEAR® Verified individual. ZEELAND, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable July ...
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
Globenewswire· 2025-05-28 12:00
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief executive officer, and president, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference, on Wednesday, June 11, 2025, at 2:00 p.m. ET. Webcast events can be accessed live through the Investors page at www.axogeninc.com. For t ...
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
Globenewswire· 2025-05-28 12:00
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. ("Bright Minds," "BMB" or the "Company") (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders, today announced that Ian McDonald, Chief Executive Officer, and Jan Torleif Pedersen, Chief Scientific Officer, will present at the 2025 Jefferies Global Healthcare C ...
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
Globenewswire· 2025-05-28 12:00
MORRISVILLE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company's Chief Executive Officer Dr. Roger Jeffs, Chief Financial Officer and Chief Operating Officer Michael Kaseta, and Chief Business Officer Jason Adair will be providing an update on the company's business during a fireside chat at the 2025 Jefferies Global Healthcare Conference on Wednesday June 4, 2025, beginning at 11:05 a.m. ET, in New York City. Access to a webcast will be available to ...
Yerbaé Joins TikTok Shop to Accelerate Growth and Expand Digital Reach
Globenewswire· 2025-05-28 12:00
Core Insights - Safety Shot, Inc. is set to merge with Yerbaé Brands Corp., which has launched on TikTok Shop to enhance its direct-to-consumer reach and increase sales [1][4] - TikTok Shop is revolutionizing retail by providing brands with a powerful platform to connect with engaged consumers through seamless in-app shopping experiences [2][3] - Yerbaé plans to leverage TikTok's audience by forming strategic partnerships with content creators to boost brand awareness and drive direct sales [3][4] Company Overview - Yerbaé Brands Corp. offers plant-based functional beverages that are zero sugar, zero calorie, and non-GMO, targeting health-conscious consumers [6][7] - The company utilizes yerba mate, a South American herb, known for its rich nutritional profile, including 196 different vitamins, minerals, and nutrients [6] - Safety Shot, Inc. has developed a patented wellness product, Sure Shot, which lowers blood alcohol content while enhancing clarity and energy [8] Strategic Initiatives - Yerbaé's entry into TikTok Shop aligns with its digital-first growth strategy, focusing on data-driven marketing and real-time consumer insights [4] - The merger with Safety Shot is expected to strengthen Yerbaé's market position and ability to engage with younger consumers seeking healthier beverage options [4][5] - The company aims to integrate its brand into viral trends and influencer-driven campaigns on TikTok to capitalize on organic product discovery [3]
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer
Globenewswire· 2025-05-28 12:00
Dr. Wright brings deep experience across a wide breadth of therapeutic areas and modalities and will guide clinical development of Wave's robust RNA medicines pipeline CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of Christopher Wright, MD, PhD, as Chief Medical Officer. Dr. Wright will join Wave's executive te ...
Alpha Modus Holdings Inc. (NASDAQ: AMOD) to Allocate 25% of Forward Revenue into Crypto Assets, Citing MicroStrategy Model and Leveraging CashX™ Infrastructure
Globenewswire· 2025-05-28 12:00
"The synergy between our physical retail infrastructure and blockchain-based financial systems presents a unique competitive edge," Alessi added. "Our CashX™ machines are not just retail enablers—they are becoming gateways to the future of decentralized finance. This dual functionality enhances utility for our partners and unlocks new revenue streams for Alpha Modus." In light of the company's crypto-forward strategy, Alpha Modus has been approached by several prominent investment banks offering credit faci ...